INVO Bioscience, Inc. Contracts & Agreements

Sublicense Agreement, dated December 21, 2023 between Cytovia Therapeutics, Inc. and NAYA Therapeutics, Inc. (fka NAYA Biosciences, Inc) (Filed With SEC on December 17, 2024)

Amendment Number 1 to Asset Purchase Agreement, dated May 17, 2024 between NAYA Therapeutics, Inc. (fka NAYA Biosciences, Inc.), Cytovia Therapeutics Holdings, Inc., and Cytovia... (Filed With SEC on December 17, 2024)

Employment Agreement, dated August 1, 2023, between Dr. Daniel Teper and NAYA Therapeutics, Inc (fka NAYA Biosciences, Inc.) (Filed With SEC on December 17, 2024)

License Agreement, dated December 19, 2023, between Inserm Transfert, Cytovia Therapeutics, Inc., and NAYA Therapeutics, Inc (fka NAYA Biosciences, Inc (Filed With SEC on December 17, 2024)

License Agreement, dated December 20, 2023 between Yissum Research Development Company of the Hebrew University of Jerusalem, Ltd, University of Rijeka Faculty of Medicine, and... (Filed With SEC on December 17, 2024)

Amended and Restated Agreement and Plan of Merger, entered into as of October 11, 2024, by and among NAYA Biosciences, Inc., INVO Bioscience, Inc., INVO Merger Sub Inc (Filed With SEC on October 15, 2024)

7.0% Senior Secured Convertible Debenture (Filed With SEC on October 15, 2024)

Joinder Agreement by and among Five Narrow Lane LP and INVO Bioscience, Inc. dated as of October 11, 2024 (Filed With SEC on October 15, 2024)

Assignment and Assumption Agreement by and among NAYA Biosciences, Inc. and INVO Bioscience, Inc. dated as of October 11, 2024 (Filed With SEC on October 15, 2024)

Second Amendment to Revenue Loan and Security Agreement by and among Steven Shum, INVO Bioscience, Inc., the Guarantors, and Decathlon Alpha V, L.P. dated October 11, 2024 (Filed With SEC on October 15, 2024)

Standard Merchant Cash Advance Agreement (Filed With SEC on October 1, 2024)

Amended and Restated First Amendment to Revenue Loan and Security Agreement (Filed With SEC on October 1, 2024)

Subordination Agreement (Filed With SEC on October 1, 2024)

Fourth Amendment to Agreement and Plan of Merger by and among INVO Bioscience, Inc., INVO Merger Sub, Inc., and NAYA Biosciences, Inc. dated as of September 12, 2024 (Filed With SEC on September 18, 2024)

Third Amendment to Agreement and Plan of Merger by and among INVO Bioscience, Inc., INVO Merger Sub, Inc., and NAYA Biosciences, Inc. dated as of May 1, 2024 (Filed With SEC on May 6, 2024)

Amendment to Securities Purchase Agreement by and between INVO Bioscience, Inc. and NAYA Biosciences, Inc. dated as of May 1, 2024 (Filed With SEC on May 6, 2024)

Amendment to Warrant Agency Agreement (Filed With SEC on April 17, 2024)

Description of Capital Stock (Filed With SEC on April 16, 2024)

Promissory Note (Filed With SEC on April 11, 2024)

First Common Stock Purchase Warrant (Filed With SEC on April 11, 2024)

Second Common Stock Purchase Warrant (Filed With SEC on April 11, 2024)

Purchase Agreement by and between INVO Bioscience, Inc. and FirstFire Global Opportunities Fund, LLC dated as of April 5, 2024 (Filed With SEC on April 11, 2024)

Common Stock Purchase Warrant dated March 27, 2024 (Filed With SEC on April 1, 2024)

Purchase Agreement by and between INVO Bioscience, Inc. and Triton Funds LP dated as of March 27, 2024 (Filed With SEC on April 1, 2024)

Agreement for the Future Purchase and Sale of Future Receipts (Filed With SEC on March 1, 2024)

Second Amendment to Agreement and Plan of Merger by and among INVO Bioscience, Inc., INVO Merger Sub, Inc., and NAYA Biosciences, Inc. dated December 27, 2023 (Filed With SEC on January 3, 2024)

Securities Purchase Agreement by and between INVO Bioscience, Inc. and NAYA Biosciences, Inc. dated as of December 29, 2023 (Filed With SEC on January 3, 2024)

Amendment to Common Stock Purchase Warrant (Filed With SEC on December 28, 2023)

Share Exchange Agreement by and between INVO Bioscience, Inc. and Cytovia Therapeutics Holdings, Inc. dated as of November 19, 2023 (Filed With SEC on November 20, 2023)

Agreement and Plan of Merger, entered into as of October 22, 2023, by and among NAYA Biosciences, Inc., INVO Bioscience, Inc., and INVO Merger Sub Inc (Filed With SEC on October 26, 2023)

Amendment to Agreement and Plan of Merger, entered into as of October 25, 2023, by and among NAYA Biosciences, Inc., INVO Bioscience, Inc., and INVO Merger Sub, Inc (Filed With SEC on October 26, 2023)

Revenue and Security Loan Agreement (Filed With SEC on October 5, 2023)

Cedar Subordination Agreement (Filed With SEC on October 5, 2023)

Form of Demand Note Subordination Letter (Filed With SEC on October 5, 2023)

Standard Merchant Cash Advance Agreement (Filed With SEC on September 1, 2023)

Shum Temporary Salary Reduction letter (Filed With SEC on August 14, 2023)

Goren Temporary Salary Reduction letter (Filed With SEC on August 14, 2023)

Physician Employment Agreement (Filed With SEC on August 11, 2023)

Management Services Agreement (Filed With SEC on August 11, 2023)

Lease Agreement (Filed With SEC on August 11, 2023)

Megid Employment Agreement (Filed With SEC on August 11, 2023)

Security Agreement (Filed With SEC on August 11, 2023)

Physician Liaison Agreement (Filed With SEC on August 11, 2023)

Directed Equity Transfer Agreement (Filed With SEC on August 11, 2023)

Placement Agency Agreement by and between the Company and the Placement Agent dated August 4, 2023 (Filed With SEC on August 8, 2023)

Warrant Agency Agreement dated August 8, 2023 between the Company and Transfer Online, Inc (Filed With SEC on August 8, 2023)

Form of Warrant (Filed With SEC on August 8, 2023)

Form of Placement Agent Warrant (Filed With SEC on August 8, 2023)

Form of Securities Purchase Agreement by and between the Company and certain investors dated August 4, 2023 (Filed With SEC on August 8, 2023)

Letter Agreement dated July 31, 2023 (Filed With SEC on August 2, 2023)

Form of Warrant Agency Agreement (Filed With SEC on August 2, 2023)

Form of Placement Agency Agreement (Filed With SEC on July 31, 2023)

Form of Common Stock Purchase Warrant (Filed With SEC on July 31, 2023)

Form of Pre-Funded Warrant (Filed With SEC on July 31, 2023)

Form of Placement Agent Warrant (Filed With SEC on July 31, 2023)

Form of Securities Purchase Agreement (Filed With SEC on July 31, 2023)

Standard Merchant Cash Advance Agreement between INVO Bioscience Inc. and Cedar Advance LLC (Filed With SEC on July 21, 2023)

Amended and Restated Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC (Filed With SEC on July 21, 2023)

Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC (Filed With SEC on July 13, 2023)

Demand Promissory Note dated July 10, 2023 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $100,000 (Filed With SEC on July 13, 2023)

Warrant dated July 10, 2023 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC (Filed With SEC on July 13, 2023)

Closing AgreementAsset Purchase Agreement (Filed With SEC on July 13, 2023)

Closing AgreementMembership Interest Purchase Agreement (Filed With SEC on July 13, 2023)

Amendment to Securities Purchase Agreement dated July 7, 2023, between the Company and Armistice (Filed With SEC on July 7, 2023)

Payoff Commitment Agreement and Confession of Judgment dated July7, 2023, between the Company and Armistice (Filed With SEC on July 7, 2023)

Termination Agreement between the Company and Lyfe Medical I, LLC dated May 10, 2023 (Filed With SEC on May 15, 2023)

Termination Letter between the Company and and Ginekaliks Dooel Skopje dated May 12, 2023 (Filed With SEC on May 15, 2023)

Description of Capital Stock (Filed With SEC on April 17, 2023)

Placement Agency Agreement by and between the Company and the Placement Agent dated March 23, 2023 (Filed With SEC on March 28, 2023)

Form of Pre-Funded Warrant (Filed With SEC on March 28, 2023)

Form of Private Placement Warrant (Filed With SEC on March 28, 2023)

Form of Placement Agent Warrant (Filed With SEC on March 28, 2023)

Form of Securities Purchase Agreement by and between the Company and the certain institutional investors dated March 23, 2023 (Filed With SEC on March 28, 2023)

Form of Convertible Promissory Note (Filed With SEC on March 23, 2023)

Form of Warrant (Filed With SEC on March 23, 2023)

Securities Purchase Agreement (Filed With SEC on March 23, 2023)

Registration Rights Agreement (Filed With SEC on March 23, 2023)

Asset Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin Fertility and Reproductive Surgery... (Filed With SEC on March 20, 2023)

Membership Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility Labs of Wisconsin, LLC, a... (Filed With SEC on March 20, 2023)

Asset Purchase Agreement dated March 16, 2023, by and among Wood Violet Fertility LLC, a Delaware limited liability company, Wisconsin Fertility and Reproductive Surgery... (Filed With SEC on March 20, 2023)

Membership Interest Purchase Agreement dated March 16, 2023 by and among Wood Violet Fertility LLC, a Delaware limited liability company, Fertility Labs of Wisconsin, LLC, a... (Filed With SEC on March 20, 2023)

Debenture dated February 17, 2023 (Filed With SEC on February 23, 2023)

Warrant dated February 17, 2023 (Filed With SEC on February 23, 2023)

Securities Purchase Agreement dated February 17, 2023 (Debenture and Warrant) (Filed With SEC on February 23, 2023)

TA Letter dated February 17, 2023 (Filed With SEC on February 23, 2023)

Securities Purchase Agreement dated February 3, 2023 (Debenture and Warrant) (Filed With SEC on February 9, 2023)

Registration Rights Agreement dated February 3, 2023 (Debenture and Warrant) (Filed With SEC on February 9, 2023)

TA Letter dated February 3, 2023 (Filed With SEC on February 9, 2023)

Equity Purchase Agreement dated February 3, 2023 (Filed With SEC on February 9, 2023)

Registration Rights Agreement dated February 3, 2023 (Equity Purchase Agreement) (Filed With SEC on February 9, 2023)

Distribution Agreement with Ming Mei Technology Co. Ltd (Filed With SEC on January 5, 2023)

Letter Agreement between INVO Bioscience, Inc. and JAG Multi Investments LLC (Filed With SEC on January 5, 2023)

Demand Promissory Note dated December 29, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $100,000 (Filed With SEC on January 5, 2023)

Warrant dated December 29, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC (Filed With SEC on January 5, 2023)

Form of Convertible Promissory Note (Filed With SEC on January 5, 2023)

Form of Warrant (Filed With SEC on January 5, 2023)

Securities Purchase Agreement (Filed With SEC on January 5, 2023)

Registration Rights Agreement (Filed With SEC on January 5, 2023)

Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $25,000 (Filed With SEC on December 19, 2022)

Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of Andax LLC in the amount of $25,000 (Filed With SEC on December 19, 2022)

Demand Promissory Note dated December 13, 2022 issued by INVO Bioscience, Inc. in favor of JAG Multi Investments LLC in the amount of $50,000 (Filed With SEC on December 19, 2022)

Demand Promissory Note dated November 29, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $60,000 (Filed With SEC on December 5, 2022)

Demand Promissory Note dated November 29, 2022 issued by INVO Bioscience, Inc. in favor of Andax LLC in the amount of $75,000 (Filed With SEC on December 5, 2022)

Demand Promissory Note dated December 2, 2022 issued by INVO Bioscience, Inc. in favor of Steven Shum in the amount of $15,000 (Filed With SEC on December 5, 2022)

Form of Demand Note (Filed With SEC on November 14, 2022)

Lease Agreement (Filed With SEC on May 26, 2022)

Exclusive Distribution Agreement (Filed With SEC on May 16, 2022)

Description of Capital Stock (Filed With SEC on March 31, 2022)

Termination Notice to Medesole Healthcare and Trading Private Limited dated March 29, 2022 (Filed With SEC on March 31, 2022)

Termination Notice to Paradigm Opportunities Fund, LP dated March 30, 2022 (Filed With SEC on March 31, 2022)

Third Amendment to Stock Purchase Agreement (Filed With SEC on February 2, 2022)

Second Amendment to Stock Purchase Agreement (Filed With SEC on January 6, 2022)

INVOcell Supply Agreement (Filed With SEC on December 2, 2021)

Amendment to Stock Purchase Agreement (Filed With SEC on December 2, 2021)

Termination Notice (Filed With SEC on November 8, 2021)

Form of Placement Agent Warrant to Purchase Common Stock (Filed With SEC on October 5, 2021)

Placement Agent Agreement, dated October 1, 2021, between the Company and the Placement Agent (Filed With SEC on October 5, 2021)

Form of Securities Purchase Agreement, dated October 1, 2021, between the Company and the purchasers party thereto (Filed With SEC on October 5, 2021)

Stock Purchase Agreement (Filed With SEC on October 4, 2021)

Share Purchase Agreement (Filed With SEC on September 7, 2021)

JV Agreement (Filed With SEC on June 30, 2021)

LLC Agreement (Filed With SEC on June 30, 2021)

Management Services Agreement (Filed With SEC on June 30, 2021)

INVOcell Supply Agreement (Filed With SEC on June 30, 2021)

INVO IP Sublicense Agreement (Filed With SEC on June 30, 2021)

JV IP License Agreement (Filed With SEC on June 30, 2021)

Guarantee of Sublease (Filed With SEC on June 30, 2021)

Employment Agreement (Filed With SEC on June 15, 2021)

Lease agreement dated March 17, 2021 between INVO Bioscience, Inc, Trustmark National Bank and HRCFG, LLC (Filed With SEC on May 17, 2021)

Partnership Agreement (Filed With SEC on April 13, 2021)

Description of Capital Stock (Filed With SEC on March 30, 2021)

Lease, dated March 2021, with Trustmark National Bank (Filed With SEC on March 30, 2021)

HRCFG INVO LLC limited liability company agreement (Filed With SEC on March 15, 2021)

Press Release dated March 15, 2021 (Filed With SEC on March 15, 2021)

Amendment No. 1 to Distribution Agreement (Filed With SEC on March 8, 2021)

Distribution Agreement (Filed With SEC on December 8, 2020)

Distribution Agreement (Filed With SEC on November 25, 2020)

Joint Venture Agreement (Malaysia) (Filed With SEC on November 25, 2020)

Joint Venture Agreement (Macedonia) (Filed With SEC on November 25, 2020)

Underwriting Agreement, dated November 12, 2020, by and between the Company and Roth Capital Partners, LLC (Filed With SEC on November 13, 2020)

Form of Underwriting Agreement (Filed With SEC on November 9, 2020)

Pre-Incorporation and Shareholders Agreement (Filed With SEC on September 30, 2020)

Form of Underwriting Agreement (Filed With SEC on September 21, 2020)

Form of Secured Convertible Note (Filed With SEC on June 26, 2020)

Form of Unit Purchase Option (Filed With SEC on June 26, 2020)

Securities Purchase Agreement (Filed With SEC on June 26, 2020)

Placement Agent Agreement (Filed With SEC on June 26, 2020)

Form of Secured Convertible Note (Filed With SEC on May 15, 2020)

Form of Unit Purchase Option (Filed With SEC on May 15, 2020)

Form of Warrant (Filed With SEC on May 15, 2020)

Form of Securities Purchase Agreement (Filed With SEC on May 15, 2020)

Form of Security Agreement (Filed With SEC on May 15, 2020)

Form of Registration Rights Agreement (Filed With SEC on May 15, 2020)

Commercial Lease Agreement dated May 1, 2019 between the registrant and PJ LLC (Filed With SEC on March 30, 2020)

Employment Agreement, dated January 15, 2020 (Filed With SEC on January 21, 2020)

Joint Venture Agreement, dated January 13, 2020, between INVO Bioscience, Inc. and Medesole Healthcare and Trading Private Limited, India (Filed With SEC on January 16, 2020)

Agreement for Release of Claims and Stock Option dated October 29, 2019 with Kathleen Karloff (Filed With SEC on November 14, 2019)

Agreement for Release of Claims and Stock Option dated October 29, 2019 with James Bowdring (Filed With SEC on November 14, 2019)

Settlement Agreement and General Release dated November 11, 2019 (Filed With SEC on November 14, 2019)

Employment Offer Letter with Steve Shum (Filed With SEC on October 15, 2019)

Form of Convertible Promissory Note 2018 (Filed With SEC on April 16, 2019)

CONVERTIBLE NOTE PURCHASE AGREEMENT (Filed With SEC on April 16, 2019)

Promissory Note August 2016 (Filed With SEC on April 16, 2019)

Form of Convertible Note Purchase Agreement 2018 (Filed With SEC on April 16, 2019)

Supply Agreement between the INVO Bioscience, Inc and Ferring International Center S.A (Filed With SEC on April 16, 2019)

College Stock, Inc. Agreement (Filed With SEC on November 16, 2009)

Kathleen Karloff Revised Loan Agreement (Filed With SEC on August 14, 2009)

Lionshare Ventures Revised Agreement (Filed With SEC on August 14, 2009)

Form of Senior Secured Convertible Promissory Note (Filed With SEC on July 17, 2009)

Form of Purchase Agreement (Filed With SEC on July 17, 2009)

Form of Warrant Purchase Agreement (Filed With SEC on July 17, 2009)

Hallmark Investments, Inc. Agreement (Filed With SEC on July 17, 2009)

Claude Ranoux Loan Agreement (Filed With SEC on May 15, 2009)

Claude Ranoux Loan Amendment (Filed With SEC on May 15, 2009)

Wakabayashi Fund, LLC Agreement (Filed With SEC on May 15, 2009)

Red Chip Securities, Inc. Agreement (Filed With SEC on May 15, 2009)

Kathleen Karloff Loan Agreement (Filed With SEC on May 15, 2009)

EX- 10.01 Employment Agreement - President CR (Filed With SEC on April 15, 2009)

EX- 10.02 Employment Agreement - Chief Financial Officer KK (Filed With SEC on April 15, 2009)

EX- 10.03 Employment Agreement - Chief Financial Officer RB (Filed With SEC on April 15, 2009)

EX- 10.04 Customer Distribution Agreement - Canada - MediTech First (Filed With SEC on April 15, 2009)

EX- 10.05 Customer Distribution Agreement - Turkey - Gonagen (Filed With SEC on April 15, 2009)

EX- 10.06 Customer Distribution Agreement - Peru- CRHL (Filed With SEC on April 15, 2009)

SHAREEXCHANGE AGREEMENT (Filed With SEC on December 12, 2008)

SECURITIES PURCHASEAGREEMENT (Filed With SEC on December 12, 2008)

Category

Industry

Companies

Contracts

INVO Bioscience, Inc. Contracts & Agreements